Voluntary transparency regarding the supply of trivalent influenza vaccines
The National Institute for Public Health and the Environment (RIVM), commissioned by the Ministry of Health, Welfare and Sport (VWS), requires the urgent supply of trivalent influenza vaccine. The corona pandemic has significantly increased the demand for influenza vaccine, making an additional stock necessary. The procurement follows a negotiated procedure without publication, meaning that RIVM negotiates directly with selected suppliers. The supplier must comply with European and national regulations for vaccines, including GMP, ISO 13485, and CE marking. A minimum quantity and a strict delivery schedule are required, with clear quality and traceability documentation. Pricing must be transparent and competitive, with possibilities for price adjustments based on delivery volumes. The procedure is aimed at rapid delivery, with an emphasis on reliability, quality, and logistical capacity.
Supplies · Onderhandeling zonder bekendmaking · European procedure
01What is being requested
The National Institute for Public Health and the Environment (RIVM), commissioned by the Ministry of Health, Welfare and Sport (VWS), requires the urgent supply of trivalent influenza vaccine. The corona pandemic has significantly increased the demand for influenza vaccine, making an additional stock necessary. The procurement follows a negotiated procedure without publication, meaning that RIVM negotiates directly with selected suppliers. The supplier must comply with European and national regulations for vaccines, including GMP, ISO 13485, and CE marking. A minimum quantity and a strict delivery schedule are required, with clear quality and traceability documentation. Pricing must be transparent and competitive, with possibilities for price adjustments based on delivery volumes. The procedure is aimed at rapid delivery, with an emphasis on reliability, quality, and logistical capacity.
The urgent procurement on behalf of VWS of additional influenza vaccines because the demand for influenza vaccine has increased significantly due to the corona epidemic.
02Outcome
Seqirus Netherlands BV / Seqirus UK Limited
03Exclusion grounds
- No specific exclusion grounds were extracted. In a European tender, the mandatory and discretionary grounds of art. 2.86/2.87 of the Dutch Procurement Act almost always apply — check the European Single Procurement Document (ESPD).
04Value in context
The contracting authority did not publish an estimated value — common for a large share of contracts. The EU threshold for leveringen is € 221.000, for reference.
05Bidders in this segment
06Legal themes that may be relevant here
07Frequently asked questions
What is the reason for this procurement?
Automatically compiled from the official tender data and documents.
08Estimated value versus the market
€ 317K
€ 892K
€ 3,3 mln
Gegunde waarden in CPV 33 · leveringen n=528